| Financial Year |
March 31 2023 |
| Monetary Funds |
797,920,929.44 |
| Held-for-trading Financial Assets |
61,954,491.64 |
| Notes Receivable |
-- |
| Accounts Receivable |
214,428,605.60 |
| Advances to Suppliers |
142,725,944.21 |
| Other Receivables |
15,393,856.28 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
208,591,802.21 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
89,101,554.02 |
| Total Current Assets |
1,691,876,319.56 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
390,348,639.59 |
| Investment Properties |
30,318,401.05 |
| Fixed Assetes |
1,250,304,694.58 |
| Under-construction Projects |
236,647,423.86 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
437,407,724.35 |
| R&D expenses |
1,485,000.00 |
| Goodwill |
11,282,333.84 |
| Long-Term Deferred and Prepaid Expenses |
58,853,828.63 |
| Deferred Income Tax Assets |
39,057,812.89 |
| Other Non-Current Assets |
49,386,677.53 |
| Sub-Total of Non-Current Assets |
2,667,181,160.60 |
| Total Assets |
4,359,057,480.16 |
| Short-Term Loans |
950,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
6,242,760.49 |
| Accounts Payable |
22,178,784.89 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
20,103,521.04 |
| Taxes Payable |
38,701,469.38 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
279,805,655.38 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
16,754,507.17 |
| Other Current Liabilities |
3,904,037.20 |
| Sub-Total of Current Liabilities |
1,367,721,791.13 |
| Long-term Loans |
200,000,000.00 |
| Bonds Payable |
331,421,212.14 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
57,878,422.23 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
720,702,927.68 |
| Total Liabilities |
2,088,424,718.81 |
| Paid-In Capital(Or Share Stock) |
288,482,704.00 |
| Capital Surplus |
542,264,235.53 |
| Surplus Reserve |
55,610,921.35 |
| LESS:Treasury Stock |
192,595,907.57 |
| Undistributed Profits |
1,364,134,098.27 |
| Minority Stockholder's Interest |
107,915,847.81 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,162,716,913.54 |
| Owner's Equity（Stockholder's Equity） |
2,270,632,761.35 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,359,057,480.16 |
